Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.

Banla M, Tchalim S, Karabou PK, Gantin RG, Agba AI, Kére-Banla A, Helling-Giese G, Heuschkel C, Schulz-Key H, Soboslay PT.

PLoS One. 2014 Jun 2;9(6):e98411. doi: 10.1371/journal.pone.0098411. eCollection 2014.

2.

Chemokines and cytokines in patients with an occult Onchocerca volvulus infection.

Lechner CJ, Gantin RG, Seeger T, Sarnecka A, Portillo J, Schulz-Key H, Karabou PK, Helling-Giese G, Heuschkel C, Banla M, Soboslay PT.

Microbes Infect. 2012 May;14(5):438-46. doi: 10.1016/j.micinf.2011.12.002. Epub 2011 Dec 13.

PMID:
22202179
3.

Applied field research for comprehensive helminth infection control.

Soboslay PT, Gantin RG, Banla M, Karabou PK, Agossou A, Douti JK, Djassoa G, Heuschkel C, Schulz-Key H, Hamm DM, Stingl P.

Wien Klin Wochenschr. 2010 Mar;122 Suppl 1:27-30. doi: 10.1007/s00508-010-1332-2.

PMID:
20376721
4.

Of mice, cattle, and humans: the immunology and treatment of river blindness.

Allen JE, Adjei O, Bain O, Hoerauf A, Hoffmann WH, Makepeace BL, Schulz-Key H, Tanya VN, Trees AJ, Wanji S, Taylor DW.

PLoS Negl Trop Dis. 2008 Apr 30;2(4):e217. doi: 10.1371/journal.pntd.0000217. Review.

5.

Antibody and cytokine responses in Dracunculus medinensis patients at distinct states of infection.

Knopp S, Amegbo IK, Hamm DM, Schulz-Key H, Banla M, Soboslay PT.

Trans R Soc Trop Med Hyg. 2008 Mar;102(3):277-83. doi: 10.1016/j.trstmh.2007.12.003. Epub 2008 Feb 6.

PMID:
18258273
6.

Microfilariae of the filarial nematode Litomosoides sigmodontis exacerbate the course of lipopolysaccharide-induced sepsis in mice.

Hübner MP, Pasche B, Kalaydjiev S, Soboslay PT, Lengeling A, Schulz-Key H, Mitre E, Hoffmann WH.

Infect Immun. 2008 Apr;76(4):1668-77. doi: 10.1128/IAI.01042-07. Epub 2008 Feb 4.

7.

Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.

Mai CS, Hamm DM, Banla M, Agossou A, Schulz-Key H, Heuschkel C, Soboslay PT.

Clin Exp Immunol. 2007 Mar;147(3):504-12.

8.

Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.

Hübner MP, Manfras BJ, Margos MC, Eiffler D, Hoffmann WH, Schulz-Key H, Kern P, Soboslay PT.

Clin Exp Immunol. 2006 Aug;145(2):243-51.

9.

Cytokine and chemokine responses in patients co-infected with Entamoeba histolytica/dispar, Necator americanus and Mansonella perstans and changes after anti-parasite treatment.

Soboslay PT, Hamm DM, Pfäfflin F, Fendt J, Banla M, Schulz-Key H.

Microbes Infect. 2006 Jan;8(1):238-47. Epub 2005 Sep 12.

PMID:
16239120
10.

Chemokines in onchocerciasis patients after a single dose of ivermectin.

Fendt J, Hamm DM, Banla M, Schulz-Key H, Wolf H, Helling-Giese G, Heuschkel C, Soboslay PT.

Clin Exp Immunol. 2005 Nov;142(2):318-26.

11.

Longitudinal clinical and serological survey of abdominal angiostrongyliasis in Guaporé, southern Brazil, from 1995 to 1999.

Graeff-Teixeira C, Goulart AH, Brum Cde O, Laitano AC, Sievers-Tostes C, Zanini GM, Bered PL, Morassutti A, Geiger S, Abrahms-Sandi E, Oliveira FT, Maurer RL, Aguiar LF, Garrido CT, da Silva AC, Rodriguez R, Schulz-Key H, Agostini AA.

Rev Soc Bras Med Trop. 2005 Jul-Aug;38(4):310-5. Epub 2005 Aug 3.

12.

Long-term observations on mouse strains experimentally infected with Angiostrongylus costaricensis.

Abrahams-Sandi E, Hoffmann WH, Graeff-Teixeira C, Schulz-Key H, Geiger SM.

Parasitol Res. 2004 Jun;93(3):230-4.

PMID:
15138807
13.

Parasite-specific antibody and cytokine profiles in newborns from Plasmodium falciparum and Entamoeba histolytica/dispar-infected mothers.

Kirch AK, Agossou A, Banla M, Hoffmann WH, Schulz-Key H, Soboslay PT.

Pediatr Allergy Immunol. 2004 Apr;15(2):133-41.

PMID:
15059189
14.

The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis.

Duerr HP, Dietz K, Schulz-Key H, Büttner DW, Eichner M.

Int J Parasitol. 2004 Mar 29;34(4):463-73.

PMID:
15013736
15.

Impact of parental onchocerciasis and intensity of transmission on development and persistence of Onchocerca volvulus infection in offspring: an 18 year follow-up study.

Kirch AK, Duerr HP, Boatin B, Alley WS, Hoffmann WH, Schulz-Key H, Soboslay PT.

Parasitology. 2003 Oct;127(Pt 4):327-35.

PMID:
14636019
16.

Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis.

Duerr HP, Dietz K, Schulz-Key H, Büttner DW, Eichner M.

Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):242-50.

PMID:
14584385
17.

Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.

Pfaff AW, Kirch AK, Hoffmann WH, Banla M, Schulz-Key H, Geiger SM, Soboslay PT.

Parasite Immunol. 2003 Jun;25(6):325-32.

18.

Pro-inflammatory (IL-1beta, IL-18) cytokines and IL-8 chemokine release by PBMC in response to Echinococcus multilocularis metacestode vesicles.

Eger A, Kirch A, Manfras B, Kern P, Schulz-Key H, Soboslay PT.

Parasite Immunol. 2003 Feb;25(2):103-5.

19.

Angiostrongylus costaricensis infection in C57BL/6 mice: MHC-II deficiency results in increased larval elimination but unaltered mortality.

Geiger SM, Hoffmann WH, Soboslay PT, Pfaff AW, Graeff-Teixeira C, Schulz-Key H.

Parasitol Res. 2003 Aug;90(5):415-20. Epub 2003 May 16.

PMID:
12750994
20.

Litomosoides sigmodontis cystatin acts as an immunomodulator during experimental filariasis.

Pfaff AW, Schulz-Key H, Soboslay PT, Taylor DW, MacLennan K, Hoffmann WH.

Int J Parasitol. 2002 Feb;32(2):171-8.

PMID:
11812494
21.

Parasite-specific antibody and cellular immune responses in human infected with Necator americanus and Oesophagostomum bifurcum.

Pit DS, Polderman AM, Baeta S, Schulz-Key H, Soboslay PT.

Parasitol Res. 2001 Sep;87(9):722-9.

PMID:
11570557
22.

A stochastic model for the aggregation of Onchocerca volvulus in nodules.

Duerr HP, Dietz K, Buttner DW, Schulz-Key H.

Parasitology. 2001 Aug;123(Pt 2):193-201.

PMID:
11510685
23.

Cellular immune responses and cytokine production in BALB/c and C57BL/6 mice during the acute phase of Angiostrongylus costaricensis infection.

Geiger SM, Abrahams-Sandi E, Soboslay PT, Hoffmann WH, Pfaff AW, Graeff-Teixeira C, Schulz-Key H.

Acta Trop. 2001 Sep 1;80(1):59-68.

PMID:
11495645
24.

Determinants for resistance and susceptibility to microfilaraemia in Litomosoides sigmodontis filariasis.

Hoffmann WH, Pfaff AW, Schulz-Key H, Soboslay PT.

Parasitology. 2001 Jun;122(Pt 6):641-9. Erratum in: Parasitology 2001 Sep;123(Pt 3):234. Soboslav PT [corrected to Soboslay PT].

PMID:
11444617
25.

Detection of the acute phase of abdominal angiostrongyliasis with a parasite-specific IgG enzyme linked immunosorbent assay.

Geiger SM, Laitano AC, Sievers-Tostes C, Agostini AA, Schulz-Key H, Graeff-Teixeira C.

Mem Inst Oswaldo Cruz. 2001 May;96(4):515-8.

26.

The role of nitric oxide in the innate resistance to microfilariae of Litomosoides sigmodontis in mice.

Pfaff AW, Schulz-Key H, Soboslay PT, Geiger SM, Hoffmann WH.

Parasite Immunol. 2000 Aug;22(8):397-405.

27.
28.

Litomosoides sigmodontis in mice: reappraisal of an old model for filarial research.

Hoffmann W, Petit G, Schulz-Key H, Taylor D, Bain O, Le Goff L.

Parasitol Today. 2000 Sep;16(9):387-9. Review.

PMID:
10951598
29.

Litomosoides sigmodontis: dynamics of the survival of microfilariae in resistant and susceptible strains of mice.

Pfaff AW, Schulz-Key H, Soboslay PT, Geiger SM, Hoffmann WH.

Exp Parasitol. 2000 Feb;94(2):67-74.

PMID:
10673342
30.

Isolation of Angiostrongylus costaricensis first-stage larvae from rodent feces on a Percoll gradient.

Graeff-Teixeira C, Geiger S, Walderich B, Hoffmann W, Abrahams E, Schulz-Key H.

J Parasitol. 1999 Dec;85(6):1170-1.

PMID:
10647052
31.
32.

Cytokine and chemokine secretion by human peripheral blood cells in response to viable Echinococcus multilocularis metacestode vesicles.

Dreweck CM, Soboslay PT, Schulz-Key H, Gottstein B, Kern P.

Parasite Immunol. 1999 Aug;21(8):433-8.

33.

Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.

Soboslay PT, Geiger SM, Drabner B, Banla M, Batchassi E, Kowu LA, Stadler A, Schulz-Key H.

Clin Exp Immunol. 1999 Jul;117(1):130-7.

34.
35.

Use of P-glycoprotein gene probes to investigate anthelmintic resistance in Haemonchus contortus and comparison with Onchocerca volvulus.

Kwa MS, Okoli MN, Schulz-Key H, Okongkwo PO, Roos MH.

Int J Parasitol. 1998 Aug;28(8):1235-40.

PMID:
9762570
36.

Antigenicity and specificity of very low molecular weight Onchocerca volvulus polypeptides in the range 2.2-12.5 kD.

Hoffmann WH, Blanke CH, Maier JM, Lüder CG, Schulz-Key H, Soboslay PT.

Trop Med Int Health. 1997 Jul;2(7):635-45.

37.

The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

Soboslay PT, Geiger SM, Weiss N, Banla M, Lüder CG, Dreweck CM, Batchassi E, Boatin BA, Stadler A, Schulz-Key H.

Immunology. 1997 Apr;90(4):592-9.

38.

Filariidae: cross-protection in filarial infections.

Geiger SM, Hoffmann W, Rapp J, Schulz-Key H, Eisenbeiss WF.

Exp Parasitol. 1996 Aug;83(3):352-6. No abstract available.

PMID:
8823252
40.

Onchocerca volvulus provides ligands for the stimulation of human gamma/delta T lymphocytes expressing V delta 1 chains.

Munk ME, Soboslay PT, Arnoldi J, Brattig N, Schulz-Key H, Kaufmann SH.

J Infect Dis. 1993 Nov;168(5):1241-7.

PMID:
8228357
41.
42.

Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients.

Schulz-Key H, Albrecht W, Heuschkel C, Soboslay PT, Banla M, Görgen H.

Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):227-9.

PMID:
8337736
43.

Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.

Soboslay PT, Dreweck CM, Hoffmann WH, Lüder CG, Heuschkel C, Görgen H, Banla M, Schulz-Key H.

Clin Exp Immunol. 1992 Sep;89(3):407-13.

44.

Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).

Lucius R, Kern A, Seeber F, Pogonka T, Willenbücher J, Taylor HR, Pinder M, Ghalib HW, Schulz-Key H, Soboslay P.

Trop Med Parasitol. 1992 Sep;43(3):139-45.

PMID:
1281926
45.

Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.

Soboslay PT, Weiss N, Dreweck CM, Taylor HR, Brotman B, Schulz-Key H, Greene BM.

Exp Parasitol. 1992 Jun;74(4):367-80.

PMID:
1592090
46.

Ivermectin-facilitated immunity.

Schulz-Key H, Soboslay PT, Hoffmann WH.

Parasitol Today. 1992 May;8(5):152-3. No abstract available.

PMID:
15463601
47.

[Ivermectin in the treatment of onchocerciasis: feasibility, compliance and efficacy of a mass treatment].

Awissi D, Heuschkel C, Banla M, Schulz-Key H.

Bull Soc Pathol Exot. 1991;84(5 Pt 5):739-49. French.

PMID:
1819423
48.

The chemotherapy of onchocerciasis. XIV. Studies with mebendazole citrate.

Awadzi K, Schulz-Key H, Edwards G, Breckenridge A, Orme M, Gilles H.

Trop Med Parasitol. 1990 Dec;41(4):383-6.

PMID:
2075382
50.

Effect of ivermectin on the vertical distribution of Onchocerca volvulus microfilariae in the skin.

Jürgens S, Schulz-Key H.

Trop Med Parasitol. 1990 Jun;41(2):165-8.

PMID:
2382096

Supplemental Content

Loading ...
Support Center